LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Smoke & Vape Shops for Sale
Convenience Stores & Lotto Businesses For Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Grocery Stores & Delis for Sale
Gas Stations & Car Washes for Sale
Home Based Business Opportunities
Beauty & Personal Care Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Environmental Businesses for Sale
Manufacturing Businesses for Sale
Pet Franchise Opportunities
Advertising & Promotional Franchises for Sale
Healthcare & Medical Franchise Opportunities
Bars & Pubs Franchises for Sale
Retail Franchise Opportunities
Manufacturing Franchises for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Vending & Kiosk Franchises for Sale
Employment & Personnel Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Houses & Condos for Sale or Lease
Places of Worship for Sale
Retail Spaces for Lease or Sale
Retail Buildings for Sale or Lease
Land & Developments for Sale
Miscellaneous Properties for Sale or Lease
Warehouses for Sale or Lease
Industrial Units for Sale or Rent
Apartment Buildings for Sale
Commercial Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: